Astrocytes are major glial cells critically in maintaining stability of the central nervous system and functional activation of astrocytes occurs rapidly in various diseased or traumatic events. We are interested in functional changes of astrocytes during the spinal cord injury, and studied expression of nerve growth factor (NGF) in activated astrocytes by mouse model of contused spinal cord injury and cell culture experiment. It revealed that the spinal cord injury resulted in apparent activation of astrocytes and microglial cells and decreased BMS scores. A larger number of astrocytes showed immunoreactivity to proNGF in the injured spinal cord areas, and proNGF expression increased and remained high level at 7 to 14dpi, which was coincided with upregulation of glial fibrillary acidic protein. The proNGF was clearly localized in both exosome-like vesicles and cytoplasm of astrocytes in culture. Electron microscopy confirmed exosome-like vesicles with proNGF-immunoreactivity in diameter sizes of 50-100 nm. Finally, cell culture with lipopolysaccharide (LPS) experiment indicated increasing expression and release of proNGF in the astrocytes with LPS exposure. This study demonstrated that reactive astrocytes increased proNGF expression after spinal cord injury, also suggesting involvement of exosome-like proNGF transport or release in triggering neuronal apoptosis and aggravating progression of spinal cord injury.
Introduction
Astrocytes, one major glial cell in the central nervous system (CNS), are critically in maintaining environment stability of CNS neurons by establishment of blood-brain-barrier and bloodspinal-barrier, regulation of glucose and glutamate metabolism, and balance of extracellular potassium (Abbott et al., 2006; Allen et al., 2017; Allen and Lyons, 2018; Wang and Bordey, 2007; Liebner et al., 2018) . Besides, functional activation of astrocytes occurs rapidly in response to traumatic, stroke and inflammatory stimulations, and astrocytes work as a central element or critical regulator during pathogenesis and progression of neurological diseases (Cekanaviciute and Buckwalter, 2016; Pekny et al., 2016; Seifert et al., 2006) . The activated astrocytes synthesize and release neuroactive substances such as neurotrophic factors and inflammatory cytokines under physiological and pathological conditions, involving in differentiation, axonal growth and synaptic plasticity of CNS neurons (Gosselin et al., 2013; Heales et al., 2004; Hillen et al., 2018; Verkhratsky et al., 2016) . The mature forms of various neurotrophic factors like the nerve growth factor (NGF), the brain-derived neurotrophic factor (BDNF) and the glial cellderived neurotrophic factor (GDNF) promote neuronal survival, while their pro-forms such as proNGF, proBDNF and proGDNF otherwise triggers neuronal cell apoptosis or neurodegeneration under the traumatic, inflammatory and neurodegenerative diseases (Fahnestock et al., 2004; Li et al., 2017; Sun et al., 2014; Xia et al., 2013) .
The spinal cord injury (SCI) is one debilitating traumatic and severely healthy problem. Functional activation of both astrocytes and microglial cells occurs remarkably in the spinal cord after traumatic spinal cord injury (Chen et al., 2015; De Luca et al., 2016) . It remains a critical question, however, if these reactive astrocytes are beneficial or not in the spinal cord injury and recovery (Chen et al., 2015; Wang and Bordey, 2007) . Previous studies showed the increased expression of neurotrophic factors in the spinal cord of SCI animal models and human patients, it was still ambiguous whether the increased neurotrophic factors present the mature form or exert neuroprotective effect (Barcelona et al., 2016; Brown et al., 2004; Kim et al., 2016; Yara et al., 2009 ). Obviously, functional balance between mature form and pro-form of neurotrophic factors contribute to final determination of cell survival or apoptosis of injured or surviving neurons (Chen et al., 2008) .
In previous study, we detected remarkable activation of both astrocytes and microglial cells in injured spinal cord after contused damage (Chen et al., 2015) . It remains obscure if these activated astrocytes are neuroprotective or detrimental in the property. In this study, we studied expression patterns of proNGF and mature NGF (mNGF) in reactive astrocytes of SCI model, with special interest in exosome-like vesicle localization in astrocytes. We identified that reactive astrocytes increased proNGF expression in SCI mouse model and proNGF was clearly localized in the exosomelike vesicles of activated astrocytes by immunofluorescence, laser scanning confocal microscopy, electron microscopy and Western blotting.
Materials and methods

Preparation of spinal cord injury model
Male adult C57BL/6 mice (n = 51) weighing 20-22 g were maintained under pathogen-free conditions and were grouped as control (sham, n = 27) and spinal cord injury (SCI, n = 24) model. The clip compression model of SCI was employed by using modified Dumont type forceps. The animal surgery was performed under aseptic condition. Mice were anesthetized with venous injection of the pentobarbital sodium solution (40 mg/kg). Laminectomy of T8 vertebra was carried out without damaging the dura. The spinal cord was compressed laterally from both sides for 30 s by using a pair of forceps with a tip width of 0.3 mm. Mice were kept in clean condition and received bladder expression twice daily postsurgery.
All animal model preparation and followed experiments were approved by the Animal Experiment Administration Committee of Fourth Military Medical University. All animal manipulations were carried out in accordance with the National Institute of Health guide for the care and use of Laboratory animals (NIH Publications, eighth edition) revised in 2012, and all efforts were made to minimize animal numbers and their suffering.
The locomotion behavior and recovery of mice after the surgery was assessed in the open field by using the Basso mouse scale (BMS) method with reference to previous studies (Chen et al., 2015; Basso et al., 2006) . The hind limb motor function was assessed on 0, 1, 3, 5, 7, 10, 14, 18, 21, 25 and 28 days post injury (dpi) in control (sham) and SCI group. Evaluations were carried out by two observers blind to the study design and data were presented in BMS scores.
Cell culture of primary astrocytes
Primary astrocytes were isolated from the spinal cord of 3day-old neonatal mice (n = 3) in protocol as previously Sun et al., 2014) . The dissociated cells were cultured in 75-cm 2 flasks coated with poly-L-lysine in the Dulbecco's modified Eagle's medium-high glucose, supplemented with 10% fetal calf serum and 100 U/ml penicillin/streptomycin, kept in humidified 5% CO 2 and 95% air at 37 • C. When cells grew confluent about 80%, the flasks were shaken at 280 rpm for 20 h at 37 • C to get rid of these surface-attaching oligodendrocytes and microglial cells. Immunofluorescence staining to glial fibrillary acidic protein (GFAP) was performed to guarantee that high percentage of astrocytes was above 95%.
Astrocyte culture with LPS experiment was performed to examine expression pattern and secretion or release of proNGF in the astrocytes. The cultured astrocyte was processed for exposure to LPS (Sigma, L6143) solution at 100 ng/ml and remained for 0, 12, 24 and 48 h. The astrocytes and culture medium were separated by centrifugation. The samples of astrocyte cells or concentrated cultured medium were respectively processed for western blotting.
2.3. Immunofluorescence and laser scanning confocal microscopy Double immunofluorescence was performed for spinal cord sections and cultured cells, in order to show activation of astrocytes and microglial cells, and localization state of NGF in the astrocytes. For immunohistochemistry, the mice at 0, 7, 14 and 28dpi (n = 3) were subjected to transcardial perfusion with 4% paraformaldehyde and followed by cryostat sections at 20 m. For immunocytochemistry of primary astrocytes, cells were rinsed with PBS and followed by 4% paraformaldehyde fixation. The spinal cord sections or cultured astrocytes were respectively incubated in the following primary antibodies: mouse anti-GFAP (Millipore, 1:1000 dilution), rabbit anti-proNGF (Sigma, 1:800 dilution), and rabbit anti-Iba1 (Wako, 1:1000 dilution) in 0.01 M PBS containing 1% bovine serum albumin and 0.1% Triton X-100 for 24 h at 4 • . After washed for three times each 10 min, sections or cells were incubated with corresponding Alexa Fluo594-conjugated donkey anti-mouse and Alexa Fluo488-conjugated anti-rabbit IgG for 2 h at room temperature. The spinal cord sections or astrocytes were respectively observed and the interested images were captured under a laser scanning confocal microscope (LSCM, FV1000, Olympus, Japan) for demonstration or further analysis.
Electron microscopy
For electron microscopic observation, the cultured astrocytes and spinal cord of mice were fixed by 0.01 M PBS solution containing 4% paraformaldehyde and 0.25% glutaraldehyde. The spinal cords of control mice (n = 3) were sectioned with vibratome at 30um thickness, followed by enzyme immunohistochemical stain to proNGF and DAB/H 2 O 2 visualization. The cultured astrocytes or spinal cord sections were then processed to dehydration, tissue mount, ultra-thick sections and observation under an electron microscope (Philip-1000). The interested images were captured by electron microscopy for demonstration.
Western blot
Western blotting of proNGF and GFAP was performed on spinal cord tissue, astrocyte cells or cultured medium, respectively. Western blotting protocol was carried out as described previously (Chen et al., 2015; Sun et al., 2014) . Fresh cell lysates for spinal tissue of mice at 0, 7, 14 and 28 dpi (n = 3), and cultured astrocytes (n = 3) were made in lysis buffer (Beyotime Biotechnol). For preparation of concentrated culture medium (n = 3), supernatant was filtered through a 0.2 m membrane to remove any cell debris. The filtrate was concentrated twice to about 50 l using Amicon Ultra-15 Centrifugal Filter Devices (sham) and SCI group. Student T-test, **P < 0.01, ***P < 0.001 vs control (n = 3); c, Comparison of BMS scores between control and SCI at time-points of 0-28dpi. Student T-test, **P < 0.01 vs control (n =. 6-24).
(Millipore). After separated in sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gels (10%), protein samples were transferred onto PVDF membranes (Millipore). Membranes were then blocked with 5% nonfat milk/TBST (0.1% Tween-20, TBS) for 1 h and incubated with following antibody, i.e. rabbit anti-proNGF (Sigma), mouse anti-GFAP (Millipore), or rabbit anti-␤-actin (Sigma) at 4 • C overnight, in which ␤-actin was used as loading control. After incubated with HRP-conjugated secondary antibody at room temperature for 1 h, immunoblot bands were detected using an advanced ECL detection kit according to manufacturer's instructions (Millipore). The interested images were digitally acquired and analyzed using the Bio-Rad System. Quantification of immunoblots was performed and data was presented in proNGF/mNGF density ratios or GFAP/␤-actin density ratios.
Statistical analyses
All data on immunopositive cells, western blot and BMS values were collected and were presented as mean ± S.E.M. Statistical significances among different groups were determined by one-way analysis of variation (ANOVA) with Newman-Keuls post hoc analysis for western blot and cell count of four group comparison, and Student t-test for BMS and cell count of two group comparison respectively. The level of significance was set at P < 0.05 for all analyses. . Student T-test, n.s. no significance, *P < 0.05, **P < 0.01, ***P < 0.001 vs sham control (n = 3).
Results
Activation of astrocytes and microglial cells in spinal cord of SCI mouse model
For confirmation of glial activation state, GFAP/Iba1 double immunofluorescence was first carried out to show distribution and morphological patterns of astrocytes and microglial cells in longitudinal section of the spinal cord. It revealed obvious activation of astrocytes and microglial cells in the spinal cord of mice after contused injury. In the spinal cord of control, both GFAPpositive astrocytes and Iba1-positive microglial cells were few and scattered in distribution with their thinner bodies and short cell processes. In SCI mouse model, those reactive astrocytes generated stronger GFAP-immunoreactivity and appeared swelling bodies and bulky protuberances or processes, and they were numerously distributed in the injured regions. Similarly, the reactive microglial cells also showed stronger Iba1-immunoreactitvity, swelled bodies and more bulky protuberance. The reactive microglial cells were numerously distributed and mixed with reactive astrocytes in the epicenter and surrounding regions of contused spinal cord (Fig. 1a) . Cell count indicated that activated astrocytes or microglial cells in SCI model are more than sham control in their numbers (Fig. 1b) .
Basso mouse scale (BMS) was performed to assess the hind limb function at each day post spinal cord injury. BMS scores were carried out by two observers blind to the study design and presented as BMS scores 10 from day 1 to day 28. BMS scales in SCI mice were significantly lower than that of control mice at each day post injury (dpi) of d1 to d27. The control mice returned to normal level of score 10 at d5 after surgical operation, while SCI group mice recovered to highest BMS of about score 7 at d17 after surgery (Fig. 1c) .
Increase of proNGF-immunoreactive astrocytes in the contused spinal cord
The GFAP/proNGF immunofluorescence was applied to show localization of proNGF in spinal cord astrocytes. In control animals, only were a few of GFAP/proNGF double positive astrocytes scarcely distributed in the white grey matter, and these astrocytes appeared thinner protuberances. Besides, a number of neuronal cells with and GFAP in control (sham) and SCI group; b, The proNGF/mNGF ratios or GFAP/␤-actin ratios shown at 0, 7, 14 and 28dpi. ANOVA, n.s. no significance, *P < 0.05, **P < 0.01, ***P < 0.001 vs 0dpi group (n = 3).
proNGF-immunoreactivity were also even distributed in the grey matter of spinal cord (Fig. 2a, b) . In SCI model, reactive astrocytes with strong immunoreactivity to GFAP/proNGF were numerously and densely distributed in injured epicenter and regions surrounding epicenter, in both grey and white matter of spinal cord. Most GFAP/proNGF double positive astrocytes appeared swelling bodies and bulky protuberances (Fig. 2c, d ). Cell count analysis indicated that GFAP/proNGF double positive astrocytes in SCI model were more than sham control in their numbers at time-point of 0, 7, 14 and 28 dpi (Fig. 2e) , whereas proNGF-immunoreactive neuronal cells were few detected in the injured spinal cord of SCI model.
Increased level of proNGF expression in the contused spinal cord
Western blot was performed to show expression and changes of proNGF in spinal cord of SCI model. Immunoblot bands of proNGF forms (34KD and 26KD), mature NGF (mNGF, 17KD), and GFAP (50KD) were observed in sham control and SCI group at timepoint of 0, 7, 14 and 28dpi (Fig. 3a) . It appeared obvious increase of proNGF forms along with decreased mNGF form in SCI model. Data analysis showed that ratios of proNGF(34KD)/mNGF(17KD) and proNGF(26KD)/mNGF(17KD) significantly increased in SCI model at time-point of 7 and 14dpi. Besides, the ratios of GFAP/␤-actin expression also increased at corresponding time-point of 7, 14dpi in the SCI model group (Fig. 3b) .
Exosome-like vesicles with proNGF-immunoreactivity in the spinal cord astrocyte
For further confirmation of localization of proNGF in astrocytes, cell culture of primary spinal cord astrocytes and GFAP/proNGF immunofluorescence with DAPI counterstaining was performed. Interestingly, we identified proNGF-immunoreactivity in both cytoplasm and exosome-like vesicles in astrocytes. GFAP-immunoreactivity appeared fibrillary structures in their cytoplasm, while exosome-like vesicles with strong proNGFimmunoreactivity were distributed in the periphery cytoplasm of the astrocytes (Fig. 4a-d) . Besides, we also observed some exosome-like vesicles with proNGF-immunoreactivity in GFAPnegative cells, which cellular property should need further investigation.
Ultrastructure of exosome-like vesicles with proNGFimmunoreactivity was confirmed in the astrocytes of cell culture and spinal cord section by electron microscope observation. In cell culture, ultrastructure of astrocyte was shown. Exosome- like vesicles with diameter of 50-100 nm were observed in the astrocytes, mainly distributed in cytoplasm periphery or processes (Fig. 5a) . In ultra-thin sections of spinal cord stained by immunohistochemistry, the astrocytes and neuronal cells showing proNGF-immunoreactivity were clearly observed. The exosomelike vesicles with proNGF-immunoreactivity were also distributed in cytoplasm of astrocytes and neuronal dendrites, and most of exosome-like vesicles appeared in diameter of 50-100 nm, which were pointed with asterisks and arrowheads representatively (Fig. 5b, c) .
Increased expression and release of proNGF in the astrocyte with LPS exposure
Cell cultured and western blot was performed to show expression pattern and release of proNGF in the cultured astrocytes with LPS exposure. GFAP/proNGF double positive cells and quantification at time-point of 0, 12, 24 and 48 h after LPS exposure (Fig. 6a,  b) . Western blot showed expression and changes of proNGF and mNGF in astrocytes at 0, 12, 24 and 48 h after LPS exposure (Fig. 6c,  d ). It confirmed existence of proNGF and mNGF in culture medium of astrocytes treated with LPS exposure (Fig. 6e, f) . Besides, MTT showed no significant change of cell viability of astrocyte with LPS exposure (data not shown), which was consistent to our previous observation (Sun et al., 2014) . Data analysis on proNGF/mNGF ratios indicated that increased expression of proNGF in the astrocytes, secretion or release of proNGF from the astrocyte occurred at 12, 24 and 48 h after LPS exposure.
Discussion
This study demonstrated interesting finding that reactive astrocytes increased proNGF expression in the mouse model of contused spinal cord injury by using immunofluorescence, confocal microscopy, electron microscopy and Western blotting. Astrocytic proNGF displayed cellular distribution in both exosome-like vesicles and homogeneous form in their cytoplasm. Activated astrocytes also increased expression level and secretion or release of proNGF after LPS exposure. This study also suggests involvement of exosome-like proNGF transport or release in triggering neuronal apoptosis and aggravating spinal cord injury progression.
It is well known that the pro-forms of neurotrophic factors, i.e. proNGF, proBDNF and pro-neurotrophin 3/4 (proNT3/4) were implicated in neuronal apoptosis and pathogenesis of neurodegenerative diseases (Barcelona et al., 2016; Chen et al., 2008; Fahnestock et al., 2004) . The proNGF and proBDNF was observed to inhibit proliferation and differentiation of neural stem cells, or inhibited neurogenesis in the hippocampus while induced glial activation (Guo et al., 2013; Li et al., 2017) . In our previous studies, presence of proNGF-p75NTR-sortilin signals was detected in the nigral dopamine neurons of lactacystin and 6-OHDA model of Parkinson's disease (PD) which might be implicated in PD progression (Chen et al., 2015; Xia et al., 2013) . The pro-form of glia cell line-derived neurotrophic factor (GDNF) was also found in the reactive astrocytes under inflammation and MPTP model of PD (Sun et al., 2014) . Increased proNGF was involved in the degeneration of basal forebrain cholinergic neurons and pathogenesis of Alzheimer's disease (AD) by p75NTR-dependent apoptotic pathways (Fahnestock and Shekari, 2019) . LPS stimulation induced increasing synthesis and release of proNGF in microglial cells, which then resulted in apoptosis of dopaminergic neuronal cells in vitro . It was found that NGF mRNA and proteins were rich in injured spinal cord, and NGF signaling was actively involved in the astrocyte/microglia-mediated immune response in the spinal cord following peripheral nerve injury (Brown et al., 2004; De Luca et al., 2016) . Moreover, microRNAs were presented in the astrocyte-secreted exosomes and these microRNAs in astrocyte-derived exosomes might function as mediators of neurogenesis or neuronal plasticity under stress, injured and disease states (Jovičić and Gitler, 2017; Lafourcade et al., 2016; Luarte et al., 2017) . For instance, microRNA 133b-containing exosomes released from astrocytes contributes to neural plasticity and improvement of functional recovery after stroke, whereas astrocyte-produced miR-146a could induce motor neuron loss in spinal muscular atrophy (Sison et al., 2017; Xin et al., 2017) . Neuronal RAR␤ signaling modulates PTEN through exosome transfer in astrocytes to inhibit glial scar formation and promote spinal cord axonal regeneration (Goncalves et al., 2015) . Recent X-ray scattering study on proNGF structural and functional characterization showed that isolated pro-domain was able to form transient intramolecular contacts with mNGF and to induce growth cone collapse of neurons (Yan et al., 2019) . Proper modulation of neurotrophic factors such as NGF, BDNF, NT3 and GDNF was thus reasonably supposed for attenuating neuronal apoptosis in spinal cord injury (Kim et al., 2016; Yara et al., 2009) .
Recently, exosomes are well documented as potent cell-to-cell communication carriers. While previous studies reported existence of exosomes in neurons, astrocytes and microglial cells, our present study further showed exosome-like vesicles with dominate proNGF level in reactive astrocytes. Being a major glial cell in the CNS, the astrocyte is actively involved in sustaining circumstance stability of neurons by regulating calcium wave, extracellular ion, glucose and glutamate transfer (Wang and Bordey, 2007) . Particularly, astrocytes play a pivotal role in blood-brain-barrier and bloodspinal-barrier by astrocyte-endothelial structure and functional interactions (Abbott et al., 2006) . Astrocytes also exhibit secretory activity for neurotrophic factors and cytokines, but their extracellular releasing methods remain obscure . Extracellular vesicles including exosome display a novel form of cell-to-cell communicating pathway in the CNS. And exosomes were released by astrocytes, neurons and microglial cells (Basso and Bonetto, 2016; Fauré et al., 2006; Turola et al., 2012) . Exocytosis and recycling of microvesicles was also observed in astrocytes (Bezzi and Volterra, 2014) . As potential mediator of neuron-glia communications, these extracellular vesicles could be regulated by intracellular protein kinase C and functional cell activation (Frühbeis et al., 2013; Gosselin et al., 2013) . Astrocyte-derived exosomes were also evidently involved in neuronal degeneration. They Y.-Y. Cheng et al. / Neuroscience Research xxx (2019) xxx-xxx Fig. 6 . Expression pattern and release of proNGF in the cultured astrocytes with LPS exposure. a-b, GFAP/proNGF double positive cells and quantification at 0, 12, 24 and 48 h after LPS exposure. c-d, Western blot shows expression levels of proNGF and mNGF in astrocytes at 0, 12, 24 and 48 h after LPS exposure. e-f, Western blot detection of proNGF and mNGF levels in the culture medium. The proNGF/mNGF ratios are shown at 0, 12, 24 and 48 h after LPS exposure. ANOVA, n.s. no significance, *P < 0.05, **P < 0.01, ***P < 0.001 vs 0 h group (n = 3).
were thus considered the potential intervention targets for the neurological diseases (Allen et al., 2017; Heales et al., 2004) . Data of our present study has provided new evidences that astrocytederived exosomes may work as critical communication mediator communicating between astrocytes, neurons and microglial cells in the spinal cord, and transported proNGF might trigger neuronal apoptosis in response to traumatic injury.
Furthermore, studies showed that exosomes worked as carriers of cargo plasma proteins in reactive astrocytes and involved in the neurodegenerative diseases of CNS, i.e. AD, PD and amyotrophic lateral sclerosis (ALS) (Abdullah et al., 2016; Basso et al., 2013; Chistiakov and Chistiakov, 2017; Goetzl et al., 2016; Yuyama and Igarashi, 2017) . The astrocyte-derived exosomes assisted transsynaptic transmission of Tau, a critical pathogen in AD (Goetzl et al., 2018; Wang et al., 2017) . Astrocytes also released those exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 that was potential apoptosis mechanism in AD (Wang et al., 2012) . Besides, ␣-synuclein-carrying extracellular vesicles derived from the reactive astrocyte, microglia and injured neurons were deadly transmitters in PD (Chang et al., 2013; Chistiakov and Chistiakov, 2017; Ngolab et al., 2017) . The ␣-synuclein further enhanced exosomes from microglial cells, which contributed propagation of PD by intercellular ␣-synuclein Transmission (Valdinocci et al., 2017) . Astrocyte-derived exosomes influenced neuronal survival under ischemic and Huntingtin's disease state (Guitart et al., 2016; Hong et al., 2017) . In addition, the reactive astrocytes from ALS induced neuron pathology, and mutant copper-zinc superoxide dismutase increased exosome release from astrocytes and implicated in disease spreading (Basso et al., 2013; Qian et al., 2017) . Finally, potential diagnostic and therapeutic clinical applications basing on exosome or exosome-containing neuroactive factors were documented for neurodegenerative diseases and traumatic injury (Kawikova and Askenase, 2015) . Exosome-related biomarkers could be specifically used as diagnostic index of CNS diseases. Inhibition or depletion or of exosome synthesis could halt propagation of overproduced phosphor-tau and alpha-synuclein for therapeutic application against AD and PD (Asai et al., 2015; Chiarini et al., 2017) . Administration of N-Propargyl Caffeamide ameliorated dopaminergic neuronal loss and motor dysfunction in PD mouse model through promoting conversion of proNGF to mNGF (Luo et al., 2018) . Indeed, impairment of enzymatic pathway that controls maturation of proNGF metabolism to mNGF was found in pathogenesis of AD and amyloid pathologies, suggesting that pharmacological manipulation of NGF metabolism has consequences in vivo for levels of proNGF/mNGF in various CNS diseases (Cuello et al., 2019) . The present study further suggests that astrocytic metabolism from proNGF to mNGF in exosome-like vesicles may be a way of therapeutic strategy for the spinal cord injury. In addition, the extracellular vesicles particularly exosomes may also be a novel delivery tool for drug or gene therapy for the CNS diseases through its permeable BBB transportation (Rufino-Ramos et al., 2017) .
In summary, significant increase of proNGF expression was found in a large number of reactive astrocytes in SCI mouse model. Release or secretion of proNGF from astrocytes was also observed in cell culture with LPS experiment. Identification of proNGF in exosome-like vesicles should deserve further investigation on its role in triggering neuronal apoptosis and aggravating spinal cord injury progression. It is expected that proper balance of proNGF/NGF ratios in reactive astrocytes may be a potential therapeutic way for spinal cord injury.
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